8,590 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Purchased by First Community Trust NA

First Community Trust NA acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 8,590 shares of the medical instruments supplier’s stock, valued at approximately $163,000.

A number of other institutional investors also recently modified their holdings of XRAY. UMB Bank n.a. boosted its holdings in DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after acquiring an additional 753 shares during the last quarter. Capital Performance Advisors LLP acquired a new position in DENTSPLY SIRONA during the 3rd quarter valued at about $27,000. Kennebec Savings Bank acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $35,000. Van ECK Associates Corp acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $42,000. Finally, Allworth Financial LP raised its stake in shares of DENTSPLY SIRONA by 40.2% during the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 625 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Trading Down 3.2 %

XRAY opened at $18.06 on Wednesday. The firm’s fifty day simple moving average is $18.96 and its 200 day simple moving average is $22.98. The stock has a market capitalization of $3.59 billion, a P/E ratio of -8.72, a P/E/G ratio of 1.93 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $36.63.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same period in the prior year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was up .4% compared to the same quarter last year. As a group, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.54%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -30.92%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Needham & Company LLC lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Evercore ISI reissued an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Finally, Morgan Stanley cut their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday, December 17th. Nine analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $27.27.

View Our Latest Stock Report on DENTSPLY SIRONA

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.